Dentsply Sirona Inc. (XRAY) News

Dentsply Sirona Inc. (XRAY): $37.65

0.48 (+1.29%)

POWR Rating

Component Grades













Filter XRAY News Items

XRAY News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

XRAY News Highlights

  • XRAY's 30 day story count now stands at 25.
  • Over the past 25 days, the trend for XRAY's stories per day has been choppy and unclear. It has oscillated between 1 and 6.
  • BAX, BEAT and SA are the most mentioned tickers in articles about XRAY.

Latest XRAY News From Around the Web

Below are the latest news stories about DENTSPLY SIRONA Inc that investors may wish to consider to help them evaluate XRAY as an investment opportunity.

Dentsply Sirona: Clear Aligner Business Will Drive Growth

Dentsply Sirona (XRAY) is a medium-growth dental company with ample revenue growth opportunities. I expect its clear aligner products will drive its revenue growth at a CAGR of around 8% in the long term, which in turn will drive its share price significantly higher. The company's bottom-line will also grow...

Alpine Capital on Seeking Alpha | February 25, 2022

Dentsply Sirona Q4 2021 Earnings Preview

Dentsply Sirona (NASDAQ:XRAY) is scheduled to announce Q4 earnings results on Monday, February 28th, before market open.The consensus EPS Estimate is $0.79 (-9.2% Y/Y) and the consensus…

Seeking Alpha | February 25, 2022

Should You Buy Dentsply Sirona (XRAY) Ahead of Earnings?

Dentsply Sirona (XRAY) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Yahoo | February 25, 2022

Dentsply Sirona Announces Latest Steps to Further Drive Its Leadership in Digital Dentistry, Including an Exciting Collaboration with Google Cloud and the Launch of a Medical-Grade 3D Printing Solution. Virtual Event to Be Held March 4.

On March 4, Dentsply Sirona, a pioneer in digital dentistry, will share details about the Company’s exciting collaboration with Google Cloud and a separate new 3D printing solution, Primeprint, in a virtual global event. Dental professionals, technicians and partners are invited to participate in this important start to the next chapter of digitalization in dentistry.CHARLOTTE, N.C., Feb. 25, 2022 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY) will introduce a series

Yahoo | February 25, 2022

Merit Medical (MMSI) Beats Q4 Earnings and Revenue Estimates

Merit Medical (MMSI) delivered earnings and revenue surprises of 42% and 3.17%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | February 25, 2022

Dentsply Sirona Announces Appointment of Dr. Dorothea Wenzel as New Board Member

CHARLOTTE, N.C., Feb. 24, 2022 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY) today announced that Dr. Dorothea Wenzel has been appointed to its Board of Directors (the “Board”), increasing the size of its Board from ten to eleven members. Dr. Wenzel has also been appointed as a member of the Audit and Finance Committee. “On behalf of Dentsply Sirona and the Board of Directors, I am pleased to welcome Dr. Wenzel to Dentsply Sirona.” said Eric K. Brandt, Chairman of t

Yahoo | February 24, 2022

DENTSPLY SIRONA (XRAY) to Post Q4 Earnings: What's in Store?

DENTSPLY SIRONA's (XRAY) fourth-quarter results are likely to reflect strong segmental performance.

Yahoo | February 22, 2022

Dentsply International (XRAY) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

Dentsply (XRAY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | February 21, 2022

OPKO Health (OPK) to Post Q4 Earnings: What's in the Cards?

OPKO Health's (OPK) fourth-quarter results are likely to reflect strength in Rayaldee.

Yahoo | February 15, 2022

What's in Store for West Pharmaceutical's (WST) Q4 Earnings?

West Pharmaceutical's (WST) fourth-quarter results are likely to reflect strength in the Proprietary Products business.

Yahoo | February 14, 2022

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.4074 seconds.